Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane

Toxicology Letters

Volumn 153, Issue 2, 2004, Pages 255-266

  Babu, R J ^a   Chatterjee, A ^a   Singh, M ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Aliphatic hydrocarbons; Chemokine; Cytokine; Skin irritation; TEWL

Indexed keywords

ALIPHATIC HYDROCARBON; DODECANE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NONANE; TETRADECANE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; ERYTHEMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RAT STRAIN; SKIN IRRITATION; SKIN WATER LOSS; WESTERN BLOTTING;

ALKANES; ANIMALS; BIOLOGICAL MARKERS; BODY WATER; CHEMOKINE CCL2; I-KAPPA B PROTEINS; INTERLEUKIN-1; IRRITANTS; MALE; NF-KAPPA B; RATS; SKIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644316672     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.04.036     Document Type: Article

References (52)

1. Allen D.G., Riviere J.E., Monteiro-Riviere N.A. Identification of early biomarkers of inflammation produced by keratinocytes exposed to jet fuels Jet A, JP-8, and JP-8 (100). J. Biochem. Mol. Toxicol. 14:2000;231-237
2. Bagley D.M., Gardner J.R., Holland G., Lewis R.W., Regnier J.F., Stringer D.A., Walker A.P. Skin irritation: reference chemicals data bank. Toxicol. In Vitro. 10:1996;1-6
3. Basketter D.A., Chamberlain M., Griffiths H.A., Rowson M., Whittle E., York M. The classification of skin irritants by human patch test. Food Chem. Toxicol. 35:1997;845-852
4. Bernhofer L.P., Barkovic S., Appa Y., Martin K.M. IL-1a and IL-1ra secretion from epidermal equivalents and the prediction of the irritation potential of mild soaps and surfactant-based consumer products. Toxicol. In Vitro. 13:1999;231-239
5. Brueckmann M., Marx A., Martin W.H., Liebe V., Lang S., Kaden J.J., Zieger W., Borggrefe M., Huhle G., Konstantin H.K. Stabilization of monocyte chemoattractant protein-1-mRNA by activated protein C. Thromb. Haemost. 89:2003;149-160
6. Chou C.C., Riviere J.E., Monteiro-Riviere N.A. The cytotoxicity of jet fuel aromatic hydrocarbons and dose-related interleukin-8 release from human epidermal keratinocytes. Arch. Toxicol. 77:2003;384-391
7. Coquette, A., Berna, N., Poumay, Y., Pittelkow, M.R., 2000. The keratinocyte in cutaneous irritation and sensitization. In: Kydonieus, A.F., Wille, J.J. (Eds.), Biochemical Modulation of Skin Reactions. CRC Press, Boca Raton, FL, pp. 125-143.
8. Coquette A., Berna N., Vandenbosch A., Rosdy M., De Wever B., Poumay Y. Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization. Toxicol. In Vitro. 17(3):2003;311-321
9. Corsini E., Galli C.L. Cytokines and irritant contact dermatitis. Toxicol. Lett. 102/103:1998;277-282
10. Corsini E., Galli C.L. Epidermal cytokines in experimental contact dermatitis. Toxicology. 142:2000;203-211
11. Corsini E., Terzoli A., Bruccoleri A., Marinovich M., Galli C.L. Induction of tumor necrosis factor-α in vivo by a skin irritant, tributylin, through activation of transcription factors: its pharmacological modulation by anti-inflammatory drugs. J. Invest. Dermatol. 108:1997;892-896
12. Dinarello C.A. Interleukin-1, interleukin-1 receptor and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16:1998;457-499
13. Draize J., Woodard G., Calvery H. Methods for the study of irritation and toxicity of substances topically applied to skin and mucous membranes. J. Pharmacol. Exp. Ther. 82:1944;377-390
14. Effendy I., Loffler H., Maibach H.I. Epidermal cytokines in murine cutaneous irritant responses. J. Appl. Toxicol. 20:2000;335-341
15. Fang J.Y., Hwang T.L., Fang C.L., Chiu H.C. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int. J. Pharm. 255:2003;153-166
16. Foreback J.L., Sarma V., Yeager N.R., Younkin E.M., Remick D.G., Ward P.A. Blood mononuclear cell production of TNF-alpha and IL-8: engagement of different signal transduction pathways including the p42 MAP kinase pathway. J. Leukoc. Biol. 64:1998;124-133
17. Freeman S., Maibach H.I. Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry. J. Am. Acad. Dermatol. 19:1988;496-502
18. Gioia F., Celleno L. The dynamics of transepidermal water loss (TEWL) from hydrated skin. Skin. Res. Technol. 8:2002;178-186
19. Goon A.T., Goh C.L. Epidemiology of occupational skin disease in Singapore 1989-1998. Contact Dermatitis. 43:2000;133-136
20. Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 346:1990;274-276
21. Gröne A. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88:2002;1-12
22. Groves R.W., Allen M.H., Ross E.L., Barker J.N.W.N., Macdonald D.M. Tumor necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132:1995;345-352
23. Heylings J.R., Diot S., Esdaile D.J., Fasano W.J., Manning L.J., Owen H.M. A prevalidation study on the in vitro skin irritation function test (SIFT) for prediction of acute skin irritation in vivo: results and evaluation of ECVAM Phase III. Toxicol. In Vitro. 17:2003;123-138
24. Ichihashi M., Ueda M., Budiyanto A., Bito T., Oka M., Fukunaga M., Tsuru K., Horikawa T. UV-induced skin damage. Toxicology. 189:2003;21-39
25. Ishizuka T., Terada N., Gerwins P., Hamelmann E., Oshiba A., Fanger G.R., Johnson G.L., Gelfand E.W. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6358-6363
26. Kabbur M.B., Rogers J.V., Gunasekar P.G., Garrett C.M., Geiss K.T., Brinkley W.W., McDougal J.N. Effect of JP-8 jet fuel on molecular and histological parameters related to acute skin irritation. Toxicol. Appl. Pharmacol. 175:2001;83-88
27. Kaminsky M., Szivos M.M., Brown K.R. Application of the Hill Top Chamber to dermal irritancy testing in the albino rabbit. J. Cutaneous Ocular Toxicol. 5:1986;81-87
28. Kanikkannan N., Singh M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int. J. Pharm. 248:2002;219-228
29. Kock A., Schwarz T., Kirnbauer R., Urbanski A., Perry P., Ansel J.C., Luger T.A. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172:1990;1609-1614
30. Kupper T.S. Immune and inflammatory process in cutaneous tissues. Mechanisms and speculations. J. Clin. Invest. 86:1990;1783-1789
31. Larrick J.W., Morhenn V., Chiang Y.L., Shi T. Activated Langerhans cells release tumor necrosis factor. J. Leukoc. Biol. 45:1989;429-433
32. Leveque J.L., de Rigal J., Saint-Leger D., Billy D. How does sodium laurye Sulfate alter the skin barrier function in man? A multiparametric approach. Skin Pharmacol. 6:1993;111-115
33. Loffler H., Pirker C., Aramaki J., Frosch P.J., Happle R., Effendy I. Evaluation of skin susceptibility to irritancy by routine patch testing with sodium lauryl sulfate. Eur. J. Dermatol. 11:2001;416-419
34. Marsella R., Olivry T. The ACVD task force on canine atopic dermatitis. XXII. Nonsteroidal anti-inflammatory pharmacotherapy. Vet. Immunol. Immunopathol. 81:2001;331-345
35. Martin A., Gallino N., Gagliardi J., Ortiz S., Lascano A.R., Diller A., Daraio M.C., Kahn A., Mariani A.L., Serra H.M. Early inflammatory markers in elicitation of allergic contact dermatitis. BMC Dermatol. 2:2002;9
36. Mitsui G., Mitsui K., Hirano T., Ohara O., Kato M., Niwano Y. Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity. Immunol. Lett. 86:2003;191-197
37. Nangia, A., Berner, B., Maibach, H.I., 1999. Transepidermal water loss measurements for assessing skin barrier function during in vitro percutaneous absorption experiments. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption: Drugs, Cosmetics, Mechanism, Methodology, vol. 97. Marcel Dekker, New York, pp. 587-594.
38. Nickoloff B.J. The cytokine network in psoriasis. Arch. Dermatol. 127:1991;871-884
39. Nuttall T.J., Knight P.A., McAleese S.M., Lamb J.R., Hill P.B. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis. Vet. Immunol. Immunopathol. 87:2002;379-384
40. Patel I.R., Attur M.G., Patel R.N., Stuchin S.A., Abagyan R.A., Abramson S.B., Amin A.R. TNF-α convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-α J. Immunol. 160:1998;4570-4579
41. Piguet P.F., Grau G.E., Houser C., Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:1991;673-679
42. Pinnacoda J., Tupker R.A., Agner T., Serup J. Guidelines for transepidermal water loss (TEWL) measurement. Contact Dermatitis. 22:1990;164-178
43. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38:2002;881-885
44. Scheuplein R.J., Blank I.J. Permeability of the skin. Physiol. Rev. 51:1971;702-747
45. Sebastiani S., Albanesi C., Pita O.D., Puddu A., Cavani G., Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch. Dermatol. Res. 293:2002;552-559
46. Seidenari S., Pepe P., Di Nardo A. Sodium hydroxide-induced irritant dermatitis as assessed by computerized elaboration of 20 MHz B-scan images and by TEWL measurement: a method for investigating skin barrier function. Acta Dermatol. Venereol. 75:1995;97-101
47. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., Shanebeck K., Grabstein K.H., Dower S.K. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6155
48. Singh S., Zhao K., Singh J. In vivo percutaneous absorption, skin barrier perturbation, and irritation from JP-8 jet fuel components. Drug Chem. Toxicol. 26:2003;135-146
49. Struyf S., Van Collie E., Paemen L., Put W., Lenaerts J.P., Proost P., Opdenakker G., Van Damme J. Synergistic induction of MCP-1 and -2 by IL-1 beta and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 63:1998;364-372
50. Welss, T., Basketter, D.A., Schroder, K.R., 2004. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol. In Vitro 18, 231-243.
51. Wigger-Alberti W., Krebs A., Elsner P. Experimental irritant contact dermatitis due to cumulative epicutaneous exposure to sodium lauryl sulphate and toluene: single and concurrent application. Br. J. Dermatol. 43:2000;551-556
52. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127